From bench to bedside: advancing mRNA therapies for cardiovascular diseases

The mRNA therapeutics field is heavily engaged in extending its reach to new cells, targets, and patient populations, and the opportunities don’t come any bigger than those in the cardiovascular diseases area. David McCall, Senior Editor, BioInsights, talks to Ajit Magadum, Assistant Professor, Department of Cardiovascular Sciences and Aging and Cardiovascular Discovery Center (ACDC), Lewis Katz School of Medicine at Temple University, about his work in identifying novel targets and addressing mRNA targeting specificity to improve patient outcomes.

Please enter your email to access content Read now